Description

[1,1-Biphenyl]-4-Sulfonamide, n-[1-[3,4-Dihydro-8-Methoxy-3-(4-Methoxyphenyl)-4-Oxo-2-Quinazolinyl]Ethyl]-n-Methyl- is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers for the development of targeted drug candidates.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel quinazolinone-based drug candidates for potential therapeutic applications.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities.
• Biochemical Research: Potential use as a tool compound or inhibitor in biochemical assays and target validation studies.
• Fine Chemical Synthesis: Serves as a sophisticated precursor for the preparation of more complex, functionalized molecules in custom synthesis projects.
• Contract Research & Development (CRO/CMO): Supplied to organizations specializing in outsourced drug discovery and process development.
• Academic Research: Utilized in university and institutional labs for exploratory research in organic and heterocyclic chemistry.

Basic Information

Product Name	[1,1-Biphenyl]-4-Sulfonamide, n-[1-[3,4-Dihydro-8-Methoxy-3-(4-Methoxyphenyl)-4-Oxo-2-Quinazolinyl]Ethyl]-n-Methyl-
CAS No.	602315-90-2
Molecular Formula	C31H29N3O5S
Molecular Weight	555.65 g/mol
Synonyms	N-[1-[3,4-Dihydro-8-methoxy-3-(4-methoxyphenyl)-4-oxo-2-quinazolinyl]ethyl]-N-methyl-[1,1'-biphenyl]-4-sulfonamide; 4'-Methyl-N-[1-[8-methoxy-3-(4-methoxyphenyl)-4-oxo-3,4-dihydro-2-quinazolinyl]ethyl]benzenesulfonamide; Biphenyl-4-sulfonamide derivative (quinazolinone); Advanced Quinazolinone Sulfonamide Intermediate; 602315-90-2; CAS 602315-90-2
EINECS	Contact for details

Quality Control

Our [1,1-Biphenyl]-4-Sulfonamide, n-[1-[3,4-Dihydro-8-Methoxy-3-(4-Methoxyphenyl)-4-Oxo-2-Quinazolinyl]Ethyl]-n-Methyl- is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the stringent requirements for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept tightly sealed in a desiccated environment and away from direct light exposure to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.